Figures and Tables

From the following article:

Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selection

Jean-Pierre Issa

Nature Clinical Practice Oncology (2005) 2, S24-S29
doi:10.1038/ncponc0355

BACK TO ARTICLE
Table 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 1

Cumulative analysis of 187 patients with myelodysplastic syndrome treated with low-dose decitabinea

Full size and legend Download PowerPoint slide (275K)
Table 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 2

Responses to decitabine in a phase I, low-dose study

Full size and legend Download PowerPoint slide (279K)
BACK TO ARTICLE